Advanced gastrointestinal neuroendocrine tumours respond unusually well to new treatment: results from the NETTER-1 trial

February 03, 2022 By wadmin

Patients with advanced gastrointestinal neuroendocrine tumours (NETs) have limited treatment options and there are few oncologists who are specialised in this relatively rare disease. But now results from a multi-centre randomised international trial of an innovative treatment show a marked improvement in the length of time patients with...

Read More

Request a Refill

8 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.